scholarly article | Q13442814 |
P356 | DOI | 10.1002/CNCR.28168 |
P698 | PubMed publication ID | 23674318 |
P2093 | author name string | John C Bailar | |
Kathryn Coe | |||
G Marie Swanson | |||
Kat Kwiatkowski | |||
P2860 | cites work | Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review | Q33300205 |
Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress? | Q34684177 | ||
Selection and description of cancer clinical trials participants--science or happenstance? | Q34810785 | ||
Reporting and representation of race/ethnicity in published randomized trials | Q39935914 | ||
Historical and current policy efforts to eliminate racial and ethnic health disparities in the United States: future opportunities for public health education research | Q40318230 | ||
Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion | Q45161542 | ||
Underrepresentation of patients 65 years of age or older in cancer-treatment trials | Q73311140 | ||
Participation in cancer clinical trials: race-, sex-, and age-based disparities | Q80179103 | ||
Policies to reduce racial and ethnic disparities in child health and health care | Q80571528 | ||
Black-White health disparities in the United States and Chicago: a 15-year progress analysis | Q82282016 | ||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2956-2963 | |
P577 | publication date | 2013-05-14 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved? | |
P478 | volume | 119 |
Q41010687 | A Randomized Controlled Trial of Opt-In Versus Opt-Out Enrollment Into a Diabetes Behavioral Intervention. |
Q52685422 | A novel approach for medical research on lymphomas: A study validation of claims-based algorithms to identify incident cases. |
Q90371291 | AAN position statement: Ethical issues in clinical research in neurology |
Q38373496 | Acceptance of Mobile Health in Communities Underrepresented in Biomedical Research: Barriers and Ethical Considerations for Scientists |
Q41818553 | Adaptation of a Cancer Clinical Trials Education Program for African American and Latina/o Community Members. |
Q38241955 | Adverse events in cancer patients with sickle cell trait or disease: case reports |
Q34943392 | Attitudes toward molecular testing for personalized cancer therapy |
Q37461392 | Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer |
Q26768632 | Barriers to a cure for HIV in women |
Q45073210 | Biospecimen donation among black and white breast cancer survivors: opportunities to promote precision medicine |
Q58699631 | Cancer Health Literacy and Willingness to Participate in Cancer Research and Donate Bio-Specimens |
Q35598300 | Cancer Research Participation Beliefs and Behaviors of a Southern Black Population: A Quantitative Analysis of the Role of Structural Factors in Cancer Research Participation. |
Q99234116 | Cancer health disparities in racial/ethnic minorities in the United States |
Q52802234 | Cohort Profile: The Haematological Malignancy Research Network (HMRN); a UK population-based patient cohort. |
Q92615912 | Connecting Community to Research: A Training Program to Increase Community Engagement in Research |
Q64109151 | Count me in: using a patient portal to minimize implicit bias in clinical research recruitment |
Q53795716 | Cultural Connections: the Key to Retention of Black, Latina, and Arab Women in the Kin Keeper(SM) Cancer Prevention Intervention Studies. |
Q37703002 | Culturally adapting a physical activity intervention for Somali women: the need for theory and innovation to promote equity |
Q39463558 | Determining If Sex Bias Exists in Human Surgical Clinical Research |
Q98186311 | Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process |
Q89491824 | Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients |
Q55510122 | Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials. |
Q99236812 | Efficacy and safety of immune checkpoint blockade in self-identified black patients with advanced non-small cell lung cancer |
Q88814369 | Empowering Latina breast cancer patients to make informed decisions about clinical trials: a pilot study |
Q90282510 | Engaging Latina breast cancer survivors in research: building a social network research registry |
Q35445265 | Evaluating a community-partnered cancer clinical trials pilot intervention with African American communities |
Q36930276 | Exclusion of Women of Childbearing Potential in Clinical Trials of Type 2 Diabetes Medications: A Review of Protocol-Based Barriers to Enrollment. |
Q47224501 | Gender differences in clinical registration trials; is there a real problem? |
Q49966627 | Global geographical variation in patient characteristics in percutaneous coronary intervention clinical trials: A systematic review and meta-analysis. |
Q33729072 | Hispanic accrual on randomized cancer clinical trials: a call to arms |
Q42680523 | How will the 'cancer moonshot' impact health disparities? |
Q48124116 | Improving the accrual of racial and ethnic minority patients in clinical trials: Time to raise the stakes. |
Q53628105 | LGBTQ Health Surveillance: Data = Power. |
Q35677959 | Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network |
Q50905419 | Mexican-American perspectives on participation in clinical trials: A qualitative study. |
Q97543409 | Missing diversity in brain tumor trials |
Q35170581 | Motivators and barriers to Latinas' participation in clinical trials: the role of contextual factors. |
Q91525021 | One and a half million medical papers reveal a link between author gender and attention to gender and sex analysis |
Q30224492 | Participating in research: attitudes within the African American church |
Q89139059 | Race-, Age-, and Gender-Based Characteristics and Toxicities of Targeted Therapies on Phase I Trials |
Q49407879 | Reporting of sex and gender in randomized controlled trials in Canada: a cross-sectional methods study. |
Q35226724 | Strategies addressing barriers to clinical trial enrollment of underrepresented populations: a systematic review. |
Q54982900 | Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is eligible. |
Q26995858 | The impact of socioeconomic status on access to cancer clinical trials |
Q40095262 | The role of functional, social, and mobility dynamics in facilitating older African Americans participation in clinical research |
Q28550510 | Twenty years and still counting: including women as participants and studying sex and gender in biomedical research |
Q39486611 | White-Black Differences in Cancer Incidence, Stage at Diagnosis, and Survival among Adults Aged 85 Years and Older in the United States |
Search more.